Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia

Cited by (863)

Items 601–700 of 863

1. Systemic Neuroprotection by Chlorogenic Acid: Antioxidant and Anti-inflammatory Evaluation in Early Neurodegeneration Induced by 3-Nitropropionic Acid in Mice
   Angélica Cantero-Téllez, Leticia Moreno‐Fierros, Gabriel Gutiérrez‐Ospina, Ana Cecilia Santiago-Prieto, Imelda Juárez, Miriam Rodríguez‐Sosa, Elizabeth Hernández · 2025 · Neurochemical Research
2. The Aggregation Continuum of α-Synuclein and Its Relevance to Brain Aging
   Anika Rana, Tejas Nikam, Bhargavi Sreepathi, Shubhini Awasthi Saraf, Saurabh Awasthi · 2025 · ACS Chemical Neuroscience
3. Immune Suppression of Glia Maturation Factor Reverses Behavioral Impairment, Attenuates Amyloid Plaque Pathology and Neuroinflammation in an Alzheimer’s Disease Mouse Model
   Mohammad Ejaz Ahmed, Govindhasamy Pushpavathi Selvakumar, Ramasamy Thangavel, Duraisamy Kempuraj, Sudhanshu P. Raikwar, Smita A. Zaheer, Shankar S. Iyer, Asgar Zaheer · 2020 · Journal of Neuroimmune Pharmacology
4. Neuroinflammation, immune response and α-synuclein pathology: how animal models are helping us to connect dots
   Tiziano Balzano, Noelia Esteban-García, Javier Blesa · 2022 · Expert Opinion on Drug Discovery
5. Sortilin acts as an endocytic receptor for α‐synuclein fibril
   Shun Ishiyama, Takafumi Hasegawa, Naoto Sugeno, Junpei Kobayashi, Shun Yoshida, Yasuo Miki, Koichi Wakabayashi, Mitsunori Fukuda, Yasushi Kawata, Takaaki Nakamura et al. · 2023 · The FASEB Journal
6. TIR-Domain-Containing Adapter-Inducing Interferon-β (TRIF) Is Essential for MPTP-Induced Dopaminergic Neuroprotection via Microglial Cell M1/M2 Modulation
   Minghui Shan, Sen Lin, Shurong Li, Yuchen Du, Haixia Zhao, Huarong Hong, Ming Yang, Xi Yang, Yongmei Wu, Liyi Ren et al. · 2017 · Frontiers in Cellular Neuroscience
7. Supramolecular organizing centers at the interface of inflammation and neurodegeneration
   Petra Sušjan, Taja Železnik Ramuta, Elvira Boršić, Sara Orehek, Iva Hafner‐Bratkovič · 2022 · Frontiers in Immunology
8. α-Synuclein Exhibits Differential Membrane Perturbation, Nucleation, and TLR2 Binding through Its Secondary Structure
   Manisha Kumari, Pranita Hanpude, Tushar Kanti Maiti · 2020 · ACS Chemical Neuroscience
9. Biochemistry & Pharmacology: Open Access
   2020
10. The lipopeptide Pam3CSK4 inhibits Rift Valley fever virus infection and protects from encephalitis
    Trevor Griesman, Cynthia M. McMillen, Seble G. Negatu, Jesse Hulahan, Kanupriya Whig, Lenka Dohnalová, Mark Dittmar, Christoph A. Thaiss, Kellie A. Jurado, D. Schultz et al. · 2024 · PLoS Pathogens
11. Alpha-synuclein shapes monocyte and macrophage cell biology and functions by bridging alterations of autophagy and inflammatory pathways
    Fiona Limanaqi, Silvia Zecchini, Pasquale Ogno, Valentina Artusa, Claudio Fenizia, Irma Saulle, Claudia Vanetti, Micaela Garziano, Sergio Strizzi, Daria Trabattoni et al. · 2024 · Frontiers in Cell and Developmental Biology
12. SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms
    Joanna Agata Motyl, Grażyna Gromadzka, Grzegorz Arkadiusz Czapski, Agata Adamczyk · 2024 · International Journal of Molecular Sciences
13. Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases
    Shun Yoshida, Takafumi Hasegawa · 2022 · Neurochemistry International
14. RNA- and ATAC-sequencing Reveals a Unique CD83+ Microglial Population Focally Depleted in Parkinson’s Disease
    Zena K. Chatila, A. Yadav, J. Mares, Xena E. Flowers, Taekyung Yun, M. Rashid, Ryan Talcoff, Z. Pelly, Ya Zhang, Philip L. De Jager et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
15. Microglial and neuronal fates following inhibition of CSF-1R in synucleinopathy mouse model
    Michiyo Iba, Yeon‐Joo Lee, Liam Horan-Portelance, Katherine Chang, Marcell P. Szabo, Robert A. Rissman, Sungyong You, Eliezer Masliah, Changyoun Kim · 2024 · Brain Behavior and Immunity
16. Glycation Produces Topologically Different α-Synuclein Oligomeric Strains and Modulates Microglia Response via the NLRP3-Inflammasome Pathway
    Manisha Kumari, Krishna Singh Bisht, Kriti Ahuja, Rajender K. Motiani, Tushar Kanti Maiti · 2024 · ACS Chemical Neuroscience
17. Unraveling the intricate link between cell death and neuroinflammation using Drosophila as a model
    Pooja Rai, Andreas Bergmann · 2024 · Frontiers in Cell and Developmental Biology
18. α-Synuclein aggregates induce mitochondrial damage and trigger innate immunity to drive neuron–microglia communication
    Ranabir Chakraborty, Stephanie Maya, Veronica Testa, Jara Montero-Muñoz, Takashi Nonaka, Masato Hasegawa, Antonella Consiglio, Chiara Zurzolo · 2026 · Nature Communications
19. Extracellular LCN2 Binding to 24p3R in Astrocytes Impedes α‐Synuclein Endocytosis in Parkinson's Disease
    Yingying Jiao, Tian Tian, Zhu Zhu, Lei Cao, Yang Liu, Rui‐An Wang, Zhi‐Yong Zhou, Cong Wang, Kezhong Zhang, Xiao Jie Lu et al. · 2025 · Advanced Science
20. Sterile innate immune mechanisms in neurodegenerative diseases
    Alyssa Ealy, Amanda M Serapiglia, Nikhil Panicker · 2025 · Journal of Biological Chemistry
21. Disease mechanisms as subtypes: Microbiome
    Salvatore Bonvegna, Roberto Cilia · 2023 · Handbook of clinical neurology
22. Expression of G2019S LRRK2 in Rat Primary Astrocytes Mediates Neurotoxicity and Alters the Dopamine Synthesis Pathway in N27 Cells via Astrocytic Proinflammatory Cytokines and Neurotrophic Factors
    Dong Hwan Ho, Hye Jung Kim, Daleum Nam, Mi Kyoung Seo, Sung Woo Park, Ilhong Son · 2024 · Current Issues in Molecular Biology
23. Immunogenetics of Parkinson’s Disease
    Itzia Jiménez-Ferrer, Maria Swanberg · 2018 · Codon Publications eBooks
24. Novel Nasal Epithelial Cell Markers of Parkinson’s Disease Identified Using Cells Treated with α-Synuclein Preformed Fibrils
    Hyojung Kim, Seok‐Jae Kang, Young Mi Jo, Sang‐Gyu Park, Seung Pil Yun, Yun‐Song Lee, Hee-Tae Kim, Nae‐Eung Lee, Yong‐Sang Kim, Seok Hyun Cho et al. · 2020 · Journal of Clinical Medicine
25. Oligomeropathies, inflammation and prion protein binding
    Gianluigi Forloni, Pietro La Vitola, Claudia Balducci · 2022 · Frontiers in Neuroscience
26. Neurodegenerative disease-associated microRNAs acting as signaling molecules modulate CNS neuron structure and viability
    Kumbol, Victor, Ivanov, Andranik, McGurran, Hugo, Schüler, Jutta, Zhai, Yuanyuan, Ludwik, Katarzyna, Hinkelmann, Lukas, Brehm, Mariam, Krüger, Christina, Küchler, Judit et al. · 2025 · Cell Communication and Signaling
27. Role of glycolysis-mediated histone lactylation in microglial activation and progression of neurodegenerative diseases
    Shuaikang Wang, Jingjing Wang, Zhiying Hu, Li Wu, Liping Huang · 2026 · Experimental Neurology
28. The role of gut-derived short-chain fatty acids in Parkinson's disease
    Mohamed Jamal Saadh, Anfal Nabeel Mustafa, Mohammed Ahmed Mustafa, Renuka Jyothi S, Hasan Khalid Dabis, G. V. Siva Prasad, Imad Jassim Mohammad, Ahmed Adnan, Ameer Hassan Idan · 2024 · Neurogenetics
29. Modulation of Urea Transport Attenuates TLR2-Mediated Microglial Activation and Upregulates Microglial Metabolism In Vitro
    Najlaa A. Al‐Thani, Dylan Zinck, Gavin S. Stewart, Derek A. Costello · 2024 · Metabolites
30. MhcII Regulates Transmission of α-Synuclein-Seeded Pathology in Mice
    Elsa Gonzalez De La Cruz, Quan Vo, Katie Moon, Karen N. McFarland, Mary J. Weinrich, Tristan Williams, Benoit I. Giasson, Paramita Chakrabarty · 2022 · International Journal of Molecular Sciences
31. Expression of transduced nucleolin promotes the clearance of accumulated α-synuclein in rodent cells and animal model
    Dong Hwan Ho, Daleum Nam, Soyeon Jeong, Mi Kyoung Seo, Sung Woo Park, Wongi Seol, Ilhong Son · 2021 · Neurobiology of Disease
32. α-Synuclein Oligomers in Skin Biopsies Predict the Worsening of Cognitive Functions in Parkinson’s Disease: A Single-Center Longitudinal Cohort Study
    Elena Contaldi, Milo Jarno Basellini, Samanta Mazzetti, Alessandra Maria Calogero, Aurora Colombo, Viviana Cereda, Gionata Innocenti, Valentina Ferri, Daniela Calandrella, Ioannis U. Isaias et al. · 2024 · International Journal of Molecular Sciences
33. Pro-Oxidative and Inflammatory Actions of Extracellular Hemoglobin and Heme: Molecular Events and Implications for Alzheimer's and Parkinson Disease
    Nicole Bon Campomayor, Hee Jin Kim, Mikyung Kim · 2025 · Biomolecules & Therapeutics
34. Microglia matters: visualizing the immune battle in Parkinson’s disease
    So Jeong Lee, Changning Wang, Jacob M. Hooker · 2025 · Journal of Clinical Investigation
35. Targeting neuroinflammation in neurodegenerative disorders: the emerging potential of semaglutide
    Vito Evola, Mayur S. Parmar · 2026 · Inflammation Research
36. Immune signaling and function in neurodegeneration
    Yvonne L. Latour, Dorian B. McGavern · 2026 · Journal of Clinical Investigation
37. Alpha-synuclein and RNA viruses: Exploring the neuronal nexus
    Anjali Gupta, Vijay Singh Bohara, Yeshavanth Banasavadi‐Siddegowda, Nitin Chaudhary, Sachin Kumar · 2024 · Virology
38. SDS3 regulates microglial inflammation by modulating the expression of the upstream kinase ASK1 in the p38 MAPK signaling pathway
    Jian Shen, Wenjia Lai, Zeyang Li, Wenyuan Zhu, Xue Bai, Zihao Yang, Qingsong Wang, Jianguo Ji · 2024 · Inflammation Research
39. α‐Synuclein activates innate immunity but suppresses interferon‐γ expression in murine astrocytes
    Jintang Wang, Zheng Chen, Jeremy D Walston, Peisong Gao, Maolong Gao, Sean Xiao Leng · 2018 · European Journal of Neuroscience
40. Investigating microglia during motor neuron degeneration using a zebrafish model
    Jessica R. Morrice, Cheryl Y. Gregory, Christopher A. Shaw · 2020 · Micron
41. The Treatment of Parkinson’s Disease with Sodium Oxybate
    Mortimer Mamelak · 2022 · Current Molecular Pharmacology
42. Oxidative Stress in Parkinson’s Disease: Role in Neurodegeneration and Targets for Therapeutics
    Rebecca Banerjee, Navneet Ammal Kaidery, Bobby Thomas · 2015 · ACS symposium series
43. Adrenergic Receptors as Pharmacological Targets for Neuroinflammation and Neurodegeneration in Parkinson’s Disease
    Monika Sharma, Patrick M. Flood · 2019 · IntechOpen eBooks
44. Targeted ErbB4 receptor activation ameliorates neuronal deficits via DOCK3 signaling in a transgenic mouse AD model
    Chong Liu, Yan Zhao, Ji-Ji Dao, Wei Zhang, Jie Liu, Yu-ke Ma, Chen-Meng Qiao, Chun Cui, Shuangxi Chen, Yan‐Qin Shen et al. · 2025 · Neurotherapeutics
45. Immunotherapy with an antibody against CD1d modulates neuroinflammation in an α-synuclein transgenic model of Lewy body like disease
    Michiyo Iba, Somin Kwon, Changyoun Kim, Marcell P. Szabo, Liam Horan-Portelance, Maria D Lopez-Ocasio, Pradeep Kumar Dagur, Cassia Overk, Robert A. Rissman, Eliezer Masliah · 2024 · Journal of Neuroinflammation
46. The gut-brain axis: Unveiling the impact of xenobiotics on neurological health and disorders
    Sushruta Koppula, Nitu L. Wankhede, Ashishkumar Kyada, Suhas Ballal, Renu Arya, Santosh Kumar Singh, Monica Gulati, Astha P Sute, Sanskruti N Sarode, Shruti P Polshettiwar et al. · 2024 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
47. Thrombomodulin reduces α-synuclein generation and ameliorates neuropathology in a mouse model of Parkinson’s disease
    Xiao-yun Niu, Xi-xiu Xie, Houzhen Tuo, Cui-ping Lv, Yaru Huang, Jie Zhu, Shiyu Liang, Xiao-yu Du, Chenggang Yang, Shengjie Hou et al. · 2024 · Cell Death Discovery
48. Inflammation: Role in Parkinson's Disease and Target for Therapy
    Patrick M. Flood, Naik Arbabzada, Monika Sharma · 2016 · InTech eBooks
49. Immunotherapeutic interventions in Parkinson's disease: Focus on α-Synuclein
    Upasana Ganguly, Sukhpal Singh, Sasanka Chakrabarti, Adesh Kumar Saini, Reena Vohra Saini · 2022 · Advances in protein chemistry and structural biology
50. Microglial activation and alpha-synuclein oligomers drive the early inflammatory phase of Parkinson’s disease
    James R. Evans, Melissa Grant‐Peters, Joseph S. Beckwith, Christina E. Toomey, Rebeka Popovic, Jonathan C. Breiter, Jonathan Brenton, Aine Fairbrother-Browne, Stephanie Strohbuecker, Joanne Lachica et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
51. Formation of seeding-competent α-synuclein aggregates in parkin-deficient iPSC-derived human neurons
    Sissel Ida Schmidt, Justyna Okarmus, Daniel Aghaie Madsen, Julie Schmidt Hansen, Emil Gregersen, Hjalte Gram, Lucas Seidelin Winkelmann, Anderson Souza Oliveira, Rachel Heon‐Roberts, Brent James Ryan et al. · 2025 · npj Parkinson s Disease
52. A unique microglia subset associated with aggressive α-synucleinopathy uncovered in a rapidly progressive multiple system atrophy cerebellar type model
    Dai Matsuse, Hiroo Yamaguchi, Masaya Harada, Yuu‐ichi Kira, Yuji Nishimura, Katsuhisa Masaki, Tatsunori Tanaka, Toru Saiga, Kei Fujishima, Eriko Matsuo et al. · 2025 · Neurobiology of Disease
53. Lack of functional STING modulates immunity but does not protect dopaminergic neurons in the alpha-synuclein pre-formed fibrils Parkinson’s disease mouse model
    Ida Hyllen Klæstrup, Line Sinnathamby Reinert, Sara Almeida Ferreira, Johanne Lauritsen, Gitte U. Toft, Hjalte Gram, Poul Henning Jensen, Søren R. Paludan, Marina Romero‐Ramos · 2025 · npj Parkinson s Disease
54. Gut microbiota and central nervous system's direct bidirectional regulation: The mechanisms of the gut–brain axis in irritable bowel syndrome
    Jinxia Zhai, Yingjie Li, Jiameng Liu, Cong Dai · 2026 · Clinical and Translational Discovery
55. Glial Plasticity and Dysfunction: Mechanistic Insights and Therapeutic Opportunities in Neurodegeneration
    Jorge Daniel Correale · 2026 · Journal of Neurochemistry
56. Exploring α-Syn’s Functions Through Ablation Models: Physiological and Pathological Implications
    Anjali Praveen, Godfried Dougnon, Hideaki Matsui · 2025 · Cellular and Molecular Neurobiology
57. Interplay of alpha-synuclein pathology and gut microbiome in Parkinson’s disease
    Ankit Srivastava, Arti Kataria, Dharmendra Kumar Yadav, Ihn Han, Eun Ha Choi · 2022 · Elsevier eBooks
58. Neuroinflammation in Dementia—Therapeutic Directions in a COVID-19 Pandemic Setting
    Mateusz Łuc, Marta Woźniak, Joanna Rymaszewska · 2022 · Cells
59. Genetic modifiers of synucleinopathies—lessons from experimental models
    Rachel Min Qi Lee, Tong‐Wey Koh · 2023 · Oxford Open Neuroscience
60. Recent advances in natural products targeting α-synuclein aggregation or clearance in Parkinson's disease
    Jay Gupta, Koneni V. Sashidhara · 2023 · European Journal of Medicinal Chemistry Reports
61. CVA16 infection causes neurological injury by engaging TLR2/MYD88/TNF-α/CXCL1 signalling pathway in hSCARB2 knock-in mice
    Yu Wang, Yong Wu, Yuya Wang, Rui Xiong, Ling Chen, Yuan Cao, Yining Wang, Yanwei Yang, Zhe Qu, Nan Xu et al. · 2025 · Antiviral Research
62. Complicity of α-synuclein oligomer and calcium dyshomeostasis in selective neuronal vulnerability in Lewy body disease
    Kenji Yamamoto · 2021 · Archives of Pharmacal Research
63. Targeting alpha-synuclein or tau for treating neurodegenerative movement disorders
    Miguel Lopez Cuina, Wassilios G. Meissner · 2022 · Revue Neurologique
64. Interneuronal In Vivo Transfer of Synaptic Proteins
    Michael Klinkenberg, Michael Helwig, Rita Pinto‐Costa, Angela Rollar, Raffaella Rusconi, Donato A. Di Monte, Ayşe Ulusoy · 2023 · Cells
65. CIITA expression is regulated by histone deacetylase enzymes and has a role in α-synuclein pre-formed fibril-induced antigen presentation in murine microglial cell line
    Caner Günaydın, Zülfinaz Betül Çelik, S. Sırrı Bilge · 2022 · Immunopharmacology and Immunotoxicology
66. The Innate Immune System in CNS Diseases; Overview
    Federico Montini, Howard L. Weiner · 2024 · Elsevier eBooks
67. Ergolide Regulates Microglial Activation and Inflammatory-Mediated Dysfunction: A Role for the Cysteinyl Leukotriene Pathway
    Danielle M. Galvin, Sara Fernandez-Garcia, Emma Dawson, Ciara Pryce, Billy P. Egan, Niamh C. Clarke, Alison Reynolds, Derek A. Costello · 2025 · International Journal of Molecular Sciences
68. Interaction Between α-Synuclein and DJ-1 in Parkinson’s Disease
    Pouya Sobhifar, David R. Brown · 2025 · Brain Sciences
69. Microglia-associated research in Parkinson’s disease: a bibliometric analysis
    Yan-Jun Chen, Ming-Rong Xie, Sheng-Qiang Zhou, Fang Liu · 2025 · Frontiers in Aging Neuroscience
70. The vicious cycle: unraveling the interplay between α-synuclein, mitochondrial dysfunction, and neuroinflammation in Parkinson’s disease
    Yu-lin Liang, Feng-ge Yang, Qiang Tang · 2026 · Journal of Neurology
71. Unraveling Neurodegeneration: Common Molecular Mechanisms and Novel Therapeutic Concepts in Major Neurodegenerative Disorders
    Fatemeh sadat Aldaghi, Zakieh Siahpoosh, Zivar Salehi, Farhad Mashayekhi, Sh. Sohrabnezhad · 2026 · Brain and Behavior
72. Suppressing ROS Production of AIE Nanoprobes by Simple Matrices Optimization for CNS Cell Observation and Minimized Influence of Cytoskeleton Morphology
    Xiaotong Chen, Yajing Jiang, Jiaxin Liu, Yu Tian, Yifan Deng, Xiaoqiong Li, Wenbo Wu, Ruoyu Zhang, Yulin Deng · 2024 · Chemical & Biomedical Imaging
73. Longitudinal correlation of cerebrospinal fluid GFAP and the progression of cognition decline in different clinical subtypes of Parkinson's disease
    Yumei Liu, Jing Wang, Fangbo Ning, Guojun Wang, Anmu Xie · 2024 · Clinical and Translational Science
74. Coronin1A Regulates the Trafficking of Alpha Synuclein in Microglia
    Karl E. Biggs, Emma N. Fikse, Faith L. Anderson, Arminja Nadine Kettenbach, Matthew C. Havrda · 2025 · Journal of Neuroscience
75. Inhalation of Acori Tatarinowii Rhizoma essential oil alleviates dyskinesia in Parkinson's disease rats through the regulation of neuroinflammation
    Yilong Hu, Yinan Zhao, Zhiguo Mao, Jingying Yang, Baoling Huang, Jinxin Miao, Mingsan Miao · 2025 · Journal of Ethnopharmacology
76. RETRACTED ARTICLE: Role of TLR2 and TLR4 Signaling in Parkinson’s Disease: An Insight into Associated Therapeutic Potential
    Gagandeep Kaur, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Arun Kumar, Sandeep Arora, SIMONA GABRIELA BUNGAU · 2021 · Journal of Molecular Neuroscience · Retracted
77. Perspective Chapter: The Role of Dopamine Receptors in Neuropsychiatric Diseases
    Burak Yaman · 2023 · IntechOpen eBooks
78. Toll-Like Receptors (TLRs) in Neurodegeneration: Integrative Approach to TLR Cascades in Alzheimer’s and Parkinson’s Diseases
    Juan Manuel Zolezzi, Sussy Bastias Candia, Nibaldo C. Inestrosa · 2019 · IntechOpen eBooks
79. Recent Advances in Neurodegeneration
    Antonella Borreca · 2019 · IntechOpen eBooks
80. α-Synuclein strains influence multiple system atrophy via central and peripheral mechanisms
    Teresa Torre-Muruzabal, Anke Van der Perren, Audrey Coens, Anna Barber Janer, Sara Camacho-Garcia, Nadia Stefanova, Ronald Melki, Veerle Baekelandt, Wouter Peelaerts · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
81. Tunneling nanotubes between neuronal and microglial cells allow bi-directional transfer of α -Synuclein and mitochondria
    Ranabir Chakraborty, Chiara Zurzolo · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
82. RNA triggers chronic stress during neuronal aging
    Kevin Rhine, Elle Epstein, Natasha M. Carlson, Xuezhen Ge, Orel Mizrahi, Anika Kamat, Anita Hermann, William R. Brothers, John Ravits, Eric J. Bennett et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
83. μGlia-Flow, an automatic workflow for microglia segmentation and classification
    Huangrui Xiong, Siling Zheng, Xiuhong Qi, Ji Liu · 2025 · Journal of Neuroscience Methods
84. Intermittent fasting and ketone bodies
    Geovana Rosa Oliveira dos Santos, Thiago Amorim de Souza Lima, Merle Gallus, Elisa Mitiko Kawamoto · 2025 · Progress in brain research
85. The Interplay Between CB2 and NMDA Receptors in Parkinson’s Disease
    Irene Reyes‐Resina, Jaume Lillo, Iu Raïch, Joan Biel Rebassa, Toni Capó, Pau Badia, Gemma Navarro · 2025 · International Journal of Molecular Sciences
86. Alzheimer's disease model explains Alzheimer’s disease incidences
    John Cheung-Yuen Chan · 2025 · Journal of Alzheimer s Disease Reports
87. Attenuating α-synuclein pathology in mice with in situ engineered astrocytes
    Xiaoyu Du, Jing Zhou, Jie Zhu, Lun Zhang, Shuai Lü, Shiyu Liang, Fang Cui, Haohan Zhang, Fei Chen, Ming-yue Jiao et al. · 2025 · Translational Neurodegeneration
88. Differential microglial responses to structurally distinct alpha-synuclein polymorphs
    Katherine Chang, Jina Kim, Michiyo Iba, Jae Hyeon Park, Alexandria Beilina, Zulfeqhar Ali Syed, Valentina Baena, Liam Horan-Portelance, Mark Cookson, Sungyong You et al. · 2025 · Molecular Brain
89. ADT-OH promotes mitophagy and suppresses the cytosolic mtDNA-cGAS-STING inflammatory cascade in microglia
    Xiao‐Ou Hou, Miao Wang, Rong Deng, Yifan Lu, Jin‐Ru Zhang, Li Ren, Jing Chen, Chun-feng Liu, Ya-ping Yang, Li‐Fang Hu · 2026 · Acta Pharmacologica Sinica
90. The cGAS-STING-Glymphatic-gut Axis in Parkinson's disease: A proposed self-amplifying triad of Neuroinflammation and therapeutic opportunity
    Ahmed M Abdelaziz · 2026 · International Immunopharmacology
91. DYRK1A and Parkinson’s disease, facts and hypotheses
    Laurent Meijer, Mattias F. Lindberg, Gaëlle Hogrel, Bernard Khor · 2026 · Neurobiology of Disease
92. Neuroinflammation in Alzheimer’s and Parkinson’s diseases: pathogenic mechanisms and therapeutic strategies
    Qin-qin Wang, Qing-qing Sun, Yong-shun Guo, Shu Yin, Jiawei Zhou · 2026 · Translational Neurodegeneration
93. Contribution of neuroinflammation, resolution, and neuroprotection in neuropsychiatric diseases
    A. A. Farooqui · 2021 · Elsevier eBooks
94. Neuroinflammation and Immune Dysfunction in the Mechanisms of Development of Parkinson’s Disease
    Galina V. Idova, Альперина Елизавета Лазаревна, Svetlana Ya. Zhanaeva · 2023 · Neuroscience and Behavioral Physiology
95. Immune Sensors, Regulators, and Effectors of Brain Health
    Çiğdem Acıoğlu, Stella Elkabes · 2024 · Springer eBooks
96. EXOSOMES AS MEDIATORS OF NEUROINFLAMMATION IN PARKINSON'S DISEASE: A REVIEW
    Mujibullah Sheikh, Arshiya Saiyyad, Pranita Jirvankar · 2025 · International Journal of Applied Pharmaceutics
97. Contribution of neuroinflammation, resolution, and neuroprotection in neurodegenerative diseases
    A. A. Farooqui · 2021 · Elsevier eBooks
98. Thoracic trauma promotes alpha-Synuclein oligomerization in murine Parkinson's disease
    Wolfgang Philipp Ruf, Annette Palmer, Lena Dörfer, Diana Wiesner, Eva Buck, Veselin Grozdanov, Jan Kassubek, Leda Dimou, Albert Christian Ludolph, Markus Stefan Huber-Lang et al. · 2022 · Neurobiology of Disease
99. Seeing I s B elieving: A lpha‐ S ynuclein Ol igomers in P arkinson's D isease B rain
    Caroline H. Williams‐Gray · 2015 · Movement Disorders
100. I nnate immunity regulates α‐synuclein clearance
     Masanori Sawamura, Norihito Uemura, Ryōsuke Takahashi · 2016 · Movement Disorders